A research scientist works inside a laboratory at the Serum Institute of India, the world’s largest vaccine manufacturer, working on vaccines against the coronavirus disease (COVID-19) in Pune. (Image used for representation: Reuters)
Whether it’s the first indigenous Covid-19 vaccine: Covaxin, Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FlueGen’s CoroFlu, or even Sanofi’s vaccine in development, all of the above names have a connection. with Hyderabad.
- News18.com
- Last update: September 13, 2020 6:22 PM IST
- Edited by: Majid Alam
- FOLLOW US:
New Delhi: Since vaccine companies around the world are in a race to deliver the Covid-19 vaccine, all eyes are on India, which makes 60% of the world’s vaccines. But among all the other cities in India, Hyderabad is the city that has the capacity to manufacture a third of the world’s vaccine, according to a Times of India report.
Whether it’s the first indigenous Covid-19 vaccine: Covaxin, Russia’s Sputnik V, Johnson & Johnson’s Ad26.Cov2.S, FlueGen’s CoroFlu, or even Sanofi’s vaccine in development, all of the above names have a connection to Hyderabad.
Whether a vaccine for Covid-19 is developed in India or not, but the city is always vital to the vaccine developed anywhere in the world, said Dr. Varaprasad Reddy, founder of Shanta Biotechnics Ltd.
“All Hyderabad vaccine companies are strong in manufacturing technology and have the ability to manufacture millions of doses to good standards,” Reddy reportedly told TOI. Reddy is waiting for the candidate vaccine from Sanofi in the first half of 2021, which will be manufactured mainly in Hyderabad.
Mahima Datla, managing director of Biological E Limited, also feels the same about Hyderabad. Your company will develop its own vaccine candidate and technology collaboration to manufacture the Johnson & Johnson vaccine in Hyderabad.
Experts suggest that most of the Covid-19 vaccine candidates that are being developed by academic labs and non-vaccine companies, which do not have the necessary infrastructure, will have no choice but to partner with India or China.
Hyderabad vaccine manufacturers are reportedly informally discussing manufacturing collaboration so that whenever a successful candidate is developed, manufacturing can be done in Hyderabad.
Indian Immunologicals Ltd, a vaccine manufacturing company has a new 20 million single dose capacity coming to Genome Valley outside Hyderabad, which is set to partner with a third-party Covid-19 vaccine manufacturer. The company is already in talks with the Russians to make the Sputnik V, TOI reported.
.
